A Phase 2, Open-Label Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE) (ENTR-601-DMD-202 (ELEVATE-LTE))
Principal Investigator
Prof Laurent Servais
Contact us
Email: childrensresearch@ouh.nhs.uk
IRAS number
1013685